Skip to main content

The Record · Denmark

Denmark. Every lock, every score.

5 forecasts on Denmark, each committed to a public criterion before the outcome was known and scored against that exact criterion afterwards. 3 resolved — 3 hit, 0 miss.

February 20272 locks resolving

RAOSCAFF prediction locks on Denmark resolving in February 2027
RefThe locked callResolvesStatus
P-276DSV FY2026 EBIT before special itemsDSV FY2026 EBIT BEFORE SPECIAL ITEMS >= DKK 22.5bn (guidance narrowed UP to DKK 23.5-25.5bn; forwarder, opposite freight exposure to P-237 Maersk) — ~0.914 Feb 2027locked 2 Sep 2026Locked
P-237Maersk FY2026 underlying EBITDAMaersk FY2026 UNDERLYING EBITDA >= USD 10.0bn (guidance raised to USD 10.5-12.5bn; underlying NOT reported EBITDA) — ~0.895 Feb 2027locked 29 Aug 2026Locked

November 20262 locks resolved

RAOSCAFF prediction locks on Denmark resolving in November 2026
RefThe locked callResolvesStatus
P-186Vestas FY2026 margin floorVestas keeps FY2026 EBIT margin floor ≥7% at Q3 (raised from 6-8%) — ~0.88HIT — locked Vestas keeping its FY2026 EBIT margin before special items guidance floor at or above 7%. Its Q3 interim report on 11 Nov 2026 narrowed the range to 7.5-8.5% (previously 7-9%); the floor rose to 7.5%. The top end fell, which is why headlines read it as a cut; the lock was on the floor.11 Nov 2026locked 13 Aug 2026Hit
P-164Maersk Q3 2026 underlying EBITDAMaersk Q3 2026 underlying EBITDA ≥US$2.2bn (~27% below Q2) — ~0.92HIT — locked Maersk Q3 2026 underlying EBITDA of at least US$2.2bn. Maersk's Q3 interim report (5 Nov 2026) shows underlying EBITDA of US$4,718m, more than double the floor, and full-year guidance was raised. Freight rates were the most volatile input this series locks, which is why the floor was wide; it was not in contention.5 Nov 2026locked 13 Aug 2026Hit

August 20261 lock resolved

RAOSCAFF prediction locks on Denmark resolving in August 2026
RefThe locked callResolvesStatus
P-92Novo Nordisk Wegovy Q2 2026Novo Wegovy franchise sales grow Q2 > Q1 2026 — ~0.80HIT - Wegovy franchise grew Q2>Q1: Wegovy pill DKK 2,256M -> 3,141M (+885M QoQ); Novo beat on Wegovy and raised FY guidance, obesity-care sales up. Pill-driven; the injectable faced YoY price pressure.5 Aug 2026locked 24 Jun 2026Hit

Open Denmark on the Atlas → · The whole record →